Upcoming webinars and recent recordings
Register now – June 10, 2026 - PACE / State of FL - This webinar will explore quality in the AI era—and how strong quality foundations are essential for safe, reliable and scalable AI and automation.
PACE/State of FL - Substance use disorders and the common laboratory tests and matrices used for controlled substance monitoring.
PACE/State of FL - The latest ASCO guidelines for selection of germline genetic testing panels for cancer patients.
Regulatory compliance and recent policy changes at the federal and state level relevant to hospital laboratory outreach programs.
PACE/State of FL - Metagenomic sequencing for diagnosing central nervous system infection. Content will be shared regarding technical details, clinical applications, and results interpretation, drawing on both current literature and practice guidelines.
PACE/State of FL - An overview of recent operational updates to the Clinical Laboratory Improvement Amendments (CLIA) and administrative process changes in the Centers for Medicare & Medicaid Services (CMS).
PACE/State of FL - The current knowledge regarding sickle cell disease from its genetic cause to the myriads of effects it can have for affected individuals.
PACE/State of FL - Internal assessments are integral to a laboratory’s quality management system (QMS).
PACE/State of FL - The latest updates in Alzheimer’s disease diagnostic criteria as well as a comprehensive review of the laboratory testing landscape.
PACE/State of FL - The critical role of planning to support innovation and transformation in today's laboratory outreach environment.
PACE/State of FL - A brief history of the FDA’s interest in LDTs and detailing new requirements.
PACE/State of FL - Laboratory tests available at Mayo Clinic Laboratories to monitor patients using monoclonal antibody therapies for treatment of inflammatory bowel disease.
P.A.C.E./Florida - Implementation of new analyzers and replacement of automation equipment in the Central Clinical Laboratory at Mayo Clinic in Rochester, Minnesota, prompted the laboratory to reassess blood collection volumes for commonly ordered tests.